CB1 – Cannabinoid Receptor Antagonist Effects on Cortisol in Cannabis-Dependent Men

REFERENCES

• United Nations Office on Drugs and Crime. 2008 World Drug Report. Vienna: United Nations Office on Drugs and Crime, 2008; 310.
   Google Scholar
• Hawks RL. The constituents of cannabis and the disposition and metabolism of cannabinoids. In The Analysis of Cannabinoids in Biological Fluids. Research Monograph 42. Hawks R, ed. Rockville: National Institute on Drug Abuse, 1982; 125–137.
   Google Scholar
• Devane WA, Dysarz FA, 3rd, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988; 34(5):605–613.
   PubMed Web of Science ®Google Scholar
• Steiner MA, Wotjak CT. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog Brain Res 2008; 170:397–432.
   PubMed Web of Science ®Google Scholar
• Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 1991; 11(2):563–583.
   PubMed Web of Science ®Google Scholar
• Murphy LL, Munoz RM, Adrian BA, Villanua MA. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis 1998; 5:432–446.
   PubMed Web of Science ®Google Scholar
• Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006; 27(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):73–100.
   PubMed Web of Science ®Google Scholar
• Brown TT, Dobs AS. Endocrine effects of marijuana. J Clin Pharmacol 2002; 42:90S–96S.
   PubMed Web of Science ®Google Scholar
• Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol Biochem Behav 1986; 24:1749–1754.
   Google Scholar
• Dax EM, Pilotte NS, Adler WH, Nagel JE, Lange WR. The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function. J Steroid Biochem 1989; 34:1–6.
   Google Scholar
• Block RI, Farinpour R, Schlechte JA. Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend 1991; 28:121–128.
   PubMed Web of Science ®Google Scholar
• D’Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, Perry E, Krystal J. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology 2008; 33(10):2505–2516.
   PubMed Web of Science ®Google Scholar
• Ranganathan M, Braley G, Pittman B, Cooper T, Perry E, Krystal J, D’Souza DC. The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology (Berl) 2009; 203(4):737–744.
   PubMed Web of Science ®Google Scholar
• Pickworth WB, Fant RV. Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans. Psychoneuroendocrinology 1998; 23(2):131–141.
   PubMed Web of Science ®Google Scholar
• Adinoff B, Iranmanesh A, Veldhuis J, Fisher L. Disturbances of the stress response: The role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World 1998; 22(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):67–72.
   PubMedGoogle Scholar
• Koob GF. Drug addiction: The yin and yang of hedonic homeostasis. Neuron 1996; 16(5):893–896.
   PubMed Web of Science ®Google Scholar
• Menzaghi F, Rassnick S, Heinrichs S, Baldwin H, Pich EM, Weiss F, Koob GF. The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann N Y Acad Sci 1994; 739:176–184.
   PubMed Web of Science ®Google Scholar
• Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995; 15(8):5439–5447.
   PubMed Web of Science ®Google Scholar
• de Fonseca FR, Carrera MRA, Navarro M, Koob GF, Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 1997; 276:2050–2053.
   PubMed Web of Science ®Google Scholar
• Cohen S. The 94-day cannabis study. Ann N Y Acad Sci 1976; 282:211–220.
   PubMed Web of Science ®Google Scholar
• Scheen A, Paquot N. Inhibitors of cannabinoid receptors and glucose metabolism. Curr Opin Clin Nutr Metab Care 2008; 11(4):505–511.
   PubMed Web of Science ®Google Scholar
• Xie S, Furjanic MA, Ferrara JJ, McAndrew NR, Ardino EL, Ngondara A, Bernstein Y, Thomas KJ, Kim E, Walker JM, Nagar S, Ward SJ, Raffa RB. The endocannabinoid system and rimonabant: A new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism–or inverse agonism–as potential obesity treatment and other therapeutic use. J Clin Pharm Therapeut 2007; 32(3):209–231.
   PubMed Web of Science ®Google Scholar
• Tucci SA, Halford JC, Harrold JA, Kirkham TC. Therapeutic potential of targeting the endocannabinoids: Implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation. Curr Med Chem 2006; 13(22):2669–2680.
   PubMed Web of Science ®Google Scholar
• Le Foll B, Gorelick D, Goldberg S. The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology 2009; 205(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):171–174.
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following oral THC administration to humans. Psychopharmacology 1999; 141:385–394.
   PubMed Web of Science ®Google Scholar
• Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA. Simultaneous quantification of delta-9-tetrahydrocannabinol (THC), 11-hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC), and 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry.J Chromatogr A 2007; 1163, 318–327.
   PubMed Web of Science ®Google Scholar
• Levine A, Zagoory-Sharon O, Feldman R, Lewis JG, Weller A. Measuring cortisol in human psychobiological studies. Physiol Behav 2007; 90(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):43–53.
   PubMed Web of Science ®Google Scholar
• Huestis MA, Gorelick DA, Heishman SJ, Preston KL,Nelson RA, Moolchan ET, Frank RA. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 2001; 58:322–330.
   PubMed Web of Science ®Google Scholar
• Huestis MA, Boyd SJ, Heishman SJ, Preston KL, Bonnet D, Le Fur G, Gorelick DA. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl) 2007; 194(4):505–515.
   PubMed Web of Science ®Google Scholar
• Fauci AS, et al., eds.. Harrison’s Principles of Internal Medicine (17th ed.). New York: McGraw-Hill, Health Professions Division, 2008.
   Google Scholar